![Stephen Pakola](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Pakola
Chief Tech/Sci/R&D Officer at
REGENXBIO INC.
Net worth: 2 M $ as of 2026-07-30
Profile
Stephen Pakola is Chief Medical Officer & EVP at REGENXBIO, Inc. since 2024 and Chief Medical Officer at Aerpio Therapeutics LLC since 2015.
Former roles include Chief Medical Officer at Oxurion NV, Chief Medical Officer at Amakem NV from 2012 to 2015, Chief Medical Officer at Thrombogenics, Inc. from 2000 to 2015, Chief Medical Officer at Aerpio Pharmaceuticals, Inc. from 2015 to 2019, and Associate Director at Boehringer Ingelheim Pharmaceuticals, Inc. from 1998 to 2000.
Education includes undergraduate and doctorate degrees from the University of Pennsylvania.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
REGENXBIO, INC. 0.31% | 2026-07-31 | 205,541 ( 0.31% ) | 2 M $ | 2026-07-30 |
Stephen Pakola active positions
| Companies | Position | Start |
|---|---|---|
| REGENXBIO INC. | Chief Tech/Sci/R&D Officer | 2019-04-16 |
Aerpio Therapeutics LLC
 Aerpio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases | Chief Tech/Sci/R&D Officer | 2015-10-05 |
Former positions of Stephen Pakola
| Companies | Position | End |
|---|---|---|
| AERPIO PHARMACEUTICALS | Chief Tech/Sci/R&D Officer | 2019-04-16 |
Amakem NV
 Amakem NV Medical/Nursing ServicesHealth Services Operates as a clinical stage ophthalmology company that provides treatments for serious eye conditions | Chief Tech/Sci/R&D Officer | 2015-09-30 |
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company engages in delivering innovative treatments for diseases of the back of the eye with a focus on diabetic eye disease | Chief Tech/Sci/R&D Officer | 2015-09-30 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Corporate Officer/Principal | 1999-12-31 |
| OXURION NV | Chief Tech/Sci/R&D Officer | - |
Training of Stephen Pakola
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
51
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
REGENXBIO, Inc.
 REGENXBIO, Inc. Pharmaceuticals: MajorHealth Technology Develops gene therapy | Health Technology |
Aerpio Therapeutics LLC
Aerpio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases | Health Technology |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Oxurion NV
 Oxurion NV Pharmaceuticals: MajorHealth Technology Develops innovative vascular biopharmaceuticals for the treatment of eye disease, vascular disease and cancer | Health Technology |
Amakem NV
Amakem NV Medical/Nursing ServicesHealth Services Operates as a clinical stage ophthalmology company that provides treatments for serious eye conditions | Health Services |
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company engages in delivering innovative treatments for diseases of the back of the eye with a focus on diabetic eye disease | Commercial Services |
Aerpio Pharmaceuticals, Inc.
 Aerpio Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
- Stock Market
- Insiders
- Stephen Pakola
